Treatment of the tumor cell lines with LLY-283 increased the level of radiation-induced cell killing, resulting in DEFs of 1.43, 1.22, and 1.23 for U251, PSN1, and MDA-MB-231, respectively (Fig. 2C). This evidence concerns the gene NT5C3A and neoplasm.